European Healthcare Expenditure on Prescribed Medicines by Country

Analyzing the European healthcare expenditure on prescribed medicines by country, Switzerland leads with €804.56 per capita, followed by Liechtenstein at €729.73 and Germany at €685.22. Southern European nations like Cyprus and Malta have moderately high expenditure, while Eastern European countries like Romania and Poland present lower values (€112.94 and €80.87 respectively). The year-on-year variations for 2023 reveal significant increases in countries like Cyprus (20.92%) and Malta (9.62%), signaling a sharp rise in healthcare spending. Conversely, the United Kingdom displays a minimal decrease of -0.11%, indicative of a stable expenditure pattern.

Looking at historical CAGR over the last five years, we see moderate to high increases in spending across most countries, reflecting growing demand for healthcare services. Countries like Switzerland, Liechtenstein, Iceland, and Slovenia show substantial annual growth rates, suggesting ongoing investment in healthcare infrastructure.

Future trends to watch include the sustained growth in Southern and Eastern Europe, driven by economic improvements and enhanced healthcare policies. Additionally, the adoption of innovative pharmaceutical technologies and personalized medicine is expected to impact overall spending patterns across these European countries.